tragic
A tragic paradox, Gilead updates and a lot of new pfizer
Adam Feuerstein / Stat Matthew Herper covers medical innovation – both his promise and his perils. Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard […]
3 mins read